|
A study in The Lancet found that treating patients with early rheumatoid arthritis with a short course of methotrexate, followed by a TNF antagonist (such as infliximab) could prevent over-treatment, reduce side effects and costs. This finding was for those patients who had an inadequate response to methotrexate alone. Other drugs are commonly used, such [...]
|
Write a comment:
|